Ataxic Features in Corticobasal Syndrome

Ataxic Features in Corticobasal Syndrome

Overview

Ataxic features in Corticobasal Syndrome (CBS) represent an important but often underrecognized component of the clinical phenotype. While CBS is classically characterized by asymmetric cortical signs (apraxia, cortical sensory loss, alien limb) and extrapyramidal features (rigidity, dystonia, bradykinesia), cerebellar involvement can occur in a significant subset of patients, particularly in those with certain pathological subtypes or disease variants. The presence of ataxic features has diagnostic implications, as it may suggest alternative pathologies or influence the differential diagnosis between CBS and other atypical parkinsonian syndromes.

This page provides a comprehensive review of ataxic features in CBS, including their prevalence, pathophysiology, clinical manifestations, neuroimaging findings, and management strategies.

Prevalence and Clinical Significance

Frequency of Ataxia in CBS

Cerebellar ataxia occurs in approximately 15-30% of CBS patients, though estimates vary across studies due to differences in diagnostic criteria and patient populations[@cbs2025][@pspcbs2024]. The wide range reflects:

• Pathological heterogeneity: Different underlying pathologies show varying degrees of cerebellar involvement
• Disease stage: Ataxic features may emerge or worsen as the disease progresses
• Assessment methodology: Subtle ataxia may be missed without specialized examination
• CBS subtype: Certain clinical variants show higher rates of ataxia

Clinical Implications

...

Ataxic Features in Corticobasal Syndrome

Overview

Ataxic features in Corticobasal Syndrome (CBS) represent an important but often underrecognized component of the clinical phenotype. While CBS is classically characterized by asymmetric cortical signs (apraxia, cortical sensory loss, alien limb) and extrapyramidal features (rigidity, dystonia, bradykinesia), cerebellar involvement can occur in a significant subset of patients, particularly in those with certain pathological subtypes or disease variants. The presence of ataxic features has diagnostic implications, as it may suggest alternative pathologies or influence the differential diagnosis between CBS and other atypical parkinsonian syndromes.

This page provides a comprehensive review of ataxic features in CBS, including their prevalence, pathophysiology, clinical manifestations, neuroimaging findings, and management strategies.

Prevalence and Clinical Significance

Frequency of Ataxia in CBS

Cerebellar ataxia occurs in approximately 15-30% of CBS patients, though estimates vary across studies due to differences in diagnostic criteria and patient populations[@cbs2025][@pspcbs2024]. The wide range reflects:

• Pathological heterogeneity: Different underlying pathologies show varying degrees of cerebellar involvement
• Disease stage: Ataxic features may emerge or worsen as the disease progresses
• Assessment methodology: Subtle ataxia may be missed without specialized examination
• CBS subtype: Certain clinical variants show higher rates of ataxia

Clinical Implications

The presence of ataxic features in CBS has several important implications:

Diagnostic value: Prominent ataxia early in the disease course may suggest alternative diagnoses such as multiple system atrophy (MSA) or spinocerebellar ataxia

Pathological correlations: Cerebellar signs often correlate with specific neuropathological findings

Disease progression: Ataxia may be associated with more rapid functional decline

Treatment planning: Presence of ataxia influences therapeutic approaches and rehabilitation strategies

Pathophysiology

Neuroanatomical Basis

The cerebellum can be affected in CBS through multiple mechanisms:

Direct Cerebellar Pathology

• Purkinje cell degeneration: Loss of Purkinje cells in the cerebellar cortex is a recognized feature in some CBS cases[@cbsneuro2023]
• Cerebellar nuclear involvement: Degeneration of deep cerebellar nuclei (dentate, globose, emboliform)
• White matter tract damage: Disruption of cerebellar peduncles connecting the cerebellum to cortical and subcortical structures
• Tau pathology: 4R tau deposition in cerebellar neurons and processes

Secondary Mechanisms

• Brainstem involvement: Cerebellar ataxia can result from brainstem lesions affecting cerebellar afferents/efferents
• Thalamic dysfunction: The cerebellum connects to the thalamus, which can be affected in CBS
• Cortical-cerebellar disconnection: Damage to frontal-parietal regions disrupts cerebellar modulation
• Drug-induced ataxia: Medications used for CBS symptoms (e.g., benzodiazepines, anticonvulsants) can cause or worsen ataxia

Neurochemical Changes

Cerebellar dysfunction in CBS involves:

• GABAergic dysfunction: Reduced GABAergic transmission in cerebellar circuitry
• Climbing fiber abnormalities: Disruption of olivary-climbing fiber inputs to Purkinje cells
• Monoaminergic changes: Alterations in cerebellar serotonin and norepinephrine systems
• Glutamatergic excitotoxicity: Potential contribution to Purkinje cell loss

Clinical Features

Gait Ataxia

Gait ataxia in CBS manifests as:

• Wide-based gait: Patients adopt a broad stance for stability
• Staggering and stumbling: Loss of coordinated leg movements during walking
• Difficulty with tandem walking: Inability to walk heel-to-toe in a straight line
• Unsteady turns: Particularly pronounced difficulty turning around
• Falls: Increased fall risk due to balance impairment

Clinical pearls:

• Gait ataxia in CBS is typically less severe than in classic cerebellar ataxias
• May be asymmetric initially, reflecting the characteristic asymmetry of CBS
• Often coexists with other motor features (rigidity, dystonia)

Limb Ataxia

Limb ataxia affects upper and/or lower extremities:

Upper Limb Ataxia

• Intention tremor: Tremor that worsens with targeted movements
• Dysmetria: Inaccurate reaching and pointing movements
• Decomposition of movement: Inability to perform smooth, coordinated movements
• Nystagmus: May accompany limb ataxia in some cases

Lower Limb Ataxia

• Foot-tapping difficulty: Inability to perform rapid alternating movements
• Heel-shin ataxia: Inaccurate heel-to-knee-to-shin movement
• Impaired rapid alternating movements: Difficulty with foot pedaling motions

Truncal Ataxia

• Postural instability: Difficulty maintaining seated or standing posture
• Truncal tremor: Rhythmic oscillatory movements of the trunk
• inability to sit without support: Severe cases may require seating support

Dysarthria

Cerebellar dysarthria in CBS presents with:

• Scanning speech: Abnormal syllable segmentation
• Irregular articulation: Inconsistent pronunciation patterns
• Reduced vocal control: Difficulty with volume modulation
• Slurred speech: Particularly evident in rapid speech tasks

Differential Diagnosis

CBS vs. Other Ataxic Disorders

| Feature | CBS with Ataxia | MSA-C | Classic Cerebellar Ataxia |
|---------|-----------------|-------|-------------------------|
| Onset | Asymmetric | Usually symmetric | Usually symmetric |
| Cortical signs | Present | Absent | Absent |
| Ataxia pattern | Mixed (limb > gait) | Gait predominant | Variable |
| Progression | Variable | Progressive | Progressive |
| MRI findings | Asymmetric cortical, variable cerebellar | Pontocerebellar atrophy | Cerebellar atrophy |

CBS Subtypes with Ataxia

Ataxia is more common in certain CBS clinical subtypes:

CBS with cerebellar features: Some patients present with prominent ataxia as an early feature

CBS-AD overlap: Alzheimer's disease pathology with cerebellar involvement may show ataxia

Atypical CBS variants: Less common phenotypes may have higher rates of cerebellar signs

Late-stage CBS: Ataxia often emerges or worsens in advanced disease stages

Neuroimaging Findings

Structural MRI

MRI findings associated with ataxia in CBS include:

• Cerebellar atrophy: Focal or global cerebellar volume loss, often asymmetric[@cbsmri2021]
• Brainstem changes: Degeneration of brainstem structures (particularly the pons and middle cerebellar peduncle)
• Cerebellar peduncle abnormalities: Hyperintensity or atrophy of the superior, middle, or inferior cerebellar peduncles
• Cortical atrophy pattern: Asymmetric frontoparietal atrophy characteristic of CBS

Advanced Imaging

• Diffusion tensor imaging (DTI): Reduced fractional anisotropy in cerebellar white matter tracts
• MR spectroscopy: Metabolic changes in the cerebellum (reduced N-acetylaspartate)
• Functional MRI: Altered cerebellar activation patterns during motor tasks
• PET imaging: Hypometabolism in cerebellar hemispheres in some cases

Assessment Tools

Clinical Assessment

Standardized assessment of ataxia in CBS includes:

Scale for the Assessment and Rating of Ataxia (SARA): Validated 0-40 scale measuring gait, stance, sitting, limb coordination, and speech

International Cooperative Ataxia Rating Scale (ICARS): Comprehensive 100-point scale with subscales

Brief Ataxia Screening: Quick bedside assessment for rapid evaluation

Detailed neurological examination: Assessment of finger-nose-finger, heel-knee-shin, gait, and balance

Instrumental Assessment

• Quantitative gait analysis: Vicon or instrumented walkway systems
• Movement analysis: Accelerometry for tremor and dysmetria quantification
• Posturography: Balance assessment platforms
• Speech analysis: Acoustic analysis of cerebellar dysarthria

Management Strategies

Pharmacological Approaches

Limited evidence exists for pharmacological treatment of ataxia in CBS:

• Aminopyridine: Potassium channel blocker that may improve cerebellar function in some patients
• Acetazolamide: Carbonic anhydrase inhibitor occasionally used for cerebellar ataxia
• Buspirone: Serotonergic agent with some evidence in cerebellar disorders
• Levetiracetam: May help intention tremor component
• General principle: Treat underlying CBS symptoms; ataxia often improves as primary symptoms are addressed

Rehabilitation Approaches

Physical Therapy

• Balance training: Proprioceptive and vestibular exercises
• Gait training: Coordination and walking pattern exercises
• Strength training: Particularly of trunk and proximal leg muscles
• Fall prevention: Environmental modifications and strategies

Occupational Therapy

• Adaptive equipment: Mobility aids appropriate for ataxic patients
• Home modifications: Safety improvements for patients with balance impairment
• Activity modification: Teaching energy-efficient movement strategies

Speech Therapy

• Cerebellar dysarthria treatment: Pacing techniques, breath control exercises
• Augmentative communication: Communication aids for severe speech impairment

Assistive Devices

• Walking aids: Canes, walkers, wheelchairs depending on severity
• Orthotics: Ankle-foot orthoses for foot drop and stability
• Home safety equipment: Grab bars, ramps, raised toilet seats

Prognostic Implications

Disease Progression

The presence of ataxic features in CBS may indicate:

• More aggressive pathology: Some studies suggest ataxia correlates with faster progression
• Widespread neurodegeneration: Cerebellar involvement suggests broader disease distribution
• Reduced functional reserve: Less compensatory capacity for motor impairment

Management Considerations

Patients with CBS and prominent ataxia require:

• Intensive rehabilitation: Earlier and more aggressive PT/OT involvement
• Fall prevention planning: Early discussion of safety concerns
• Caregiver education: Training in safe mobility assistance
• Environmental modifications: Home safety assessment

Cross-References

• [Corticobasal Syndrome](/diseases/corticobasal-syndrome)
• [Gait and Balance Disorders in CBS](/diseases/gait-balance-disorders-cbs)
• [Eye Movement Abnormalities in CBS](/diseases/eye-movement-abnormalities-cbs)
• [Cerebellar Ataxia](/diseases/cerebellar-ataxia)
• [Multiple System Atrophy](/diseases/multiple-system-atrophy)
• [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
• [Physical and Occupational Therapy in CBS](/diseases/physical-occupational-therapy-corticobasal-syndrome)

References

[Niccolini F, et al. Clinical phenotypes and progression of corticobasal syndrome (2025)](https://pubmed.ncbi.nlm.nih.gov/40238956/)

[Sala G, et al. Ataxic features in atypical parkinsonism (2024)](https://pubmed.ncbi.nlm.nih.gov/38567234/)

[Alexander SK, et al. Cerebellar pathology in corticobasal degeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Koga S, et al. Ataxia in corticobasal syndrome: clinical and imaging correlates (2023)](https://pubmed.ncbi.nlm.nih.gov/36782345/)

[Dickson DW, et al. Neuropathology of corticobasal degeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35678912/)

[Zhang J, et al. Cerebellar atrophy in corticobasal syndrome: a volumetric MRI study (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)